We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Self-Anchoring Suture Needs No Knot

By HospiMedica staff writers
Posted on 22 Nov 2004
A new self-anchoring suture is designed for wound closure of dermal tissue. The suture has been cleared by the U.S. Food and Drug Administration (FDA).

The Barbed Polydioxanone suture is the first in a series of tissue repair devices being developed by Quill Medical, Inc. (Research Triangle Park, NC, USA), based on the company's patented new suture technology. More than 40 obstetrician/gynecologists participated in a trial involving 195 patients to demonstrate the performance of the suture in closing a cesarian section incision. The doctors found the suture to be easier and faster to use than conventional suture material, the company advises.

"Surgeons worldwide use hundreds of millions of sutures each year to close wounds and repair tissue, all of which are secured with suture knots,” observed Matthew Megaro, president and CEO of Quill Medical. "The Quill self-anchoring suture eliminates painstaking and time-consuming knot-tying, a benefit to nearly all surgeons and patients.”

The self-anchoring suture was invented by Gregory Ruff, M.D., chairman of Quill Medical, who for 17 years was a member of the department of surgery at Duke University Medical Center. Quill's products target diverse applications in general surgery, orthopedic, and aesthetics fields.




Related Links:
Quill Medical
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Patient Preoperative Skin Preparation
BD ChloraPrep
Blood Gas Analyzer
i-Check200

Channels

Artificial Intelligence

view channel
Image: Coredio’s CPSE is a a software-as-a-medical-device platform designed for use with consumer smartwatches and standard blood pressure cuffs in clinical and home settings under physician supervision (Photo courtesy of Coredio)

AI Platform Supports Noninvasive Remote Hemodynamic Monitoring in Heart Failure

Heart failure remains a leading cause of hospitalization in adults over 65, affecting more than 6.7 million people in the U.S. Clinicians often lose visibility into hemodynamic deterioration once patients... Read more